Home

NGL Fine-Chem Limited

NGLFINE.NSNSEHealthcare
₹3,450.00Today0.23% · -₹7.80
Day rangeTrading above day high
₹0.00₹0.00
Open
₹0.00
Prev close
₹3,457.80
AskWarren SignalsUpdated 21:36 IST
Momentum Bearish(-0.23% today)Volume 27% Below Avg52W Position Near 52W High
Volume
5.0K
27% below avg
Avg vol (20D)
6.9K
20-day baseline
Mkt cap
₹2,130Cr
Small Cap
P/E TTM
43.5×

Trade NGL Fine-Chem Limited with Artha

Sign in to place orders, set alerts, and sync your watchlist.

Sign in to trade

NGL Fine-Chem Limited manufactures and sells pharmaceuticals and intermediates for usage in veterinary and human health in India, Europe, the Asia Pacific, the United States, and internationally. The company offers animal health pharmaceutical ingredients, such as homidium chloride, nitroxynil, clorsulon, parvaquone, buparvaquone, isometamidium chloride hydrochloride, toldimfos sodium, butaphosphan, imidocarb dipropionate, triclabendazole, rafoxanide, diminazene aceturate, s-methoprene, carprofen, diminazene diaceturate, ractopamine HCI, toltrazuril, decoquinate, amitraz, marbofloxacin, flunixin meglumine, praziquantel, fenbendazole, and xylazine hydrochloride. It also provides human health pharmaceutical ingredients, including nitazoxanide and atovaquone; and intermediates and specialty chemicals comprising 1,4,7-Trimethyl-1,4,7-Triazacylononane and N-ethyl glucamine. In addition, the company offers finished dosage forms, including diminazene aceturate granules and homidium chloride tablets. NGL Fine-Chem Limited was incorporated in 1981 and is based in Mumbai, India.

Classification

SectorHealthcare
IndustryDrug Manufacturers - General
Stock ExchangeNSE

Identifiers

Ticker SymbolNGLFINE.NS

Company Info

HeadquartersNot available
Employees498
Save watchlists across devicesSet price alerts that buzz your phoneConnect Zerodha for one-tap trades
Create free account

We use analytics cookies to understand how you use Artha and improve your experience. No data is sold to third parties.